The majority of elderly nursing home patients who undergo surgical or endovascular revascularization for lower-extremity PAD are unlikely to have improvements in function, and a high percentage will ...

BARCELONA, SPAIN — Patients with peripheral arterial disease (PAD) should receive multidisciplinary management from a "vascular team" that involves specialties outside of cardiovascular medicine and ...

Improvements in medical therapy, carotid-artery stenting, and carotid endarterectomy call into question the preferred management of asymptomatic carotid stenosis. Whether adding revascularization to ...

Lower extremity artery disease (LEAD) is a leading cause of morbidity and mortality worldwide, affecting hundreds of millions of people. On top of that, LEAD also represents a prominent marker of ...

CLEVELAND, OH — Postexercise ankle-brachial index (ABI) may be a useful predictor of CV outcomes in patients with peripheral artery disease (PAD), including those with a normal resting ABI, suggests ...

Both the incidence and degree of bleeding events after peripheral revascularization match what’s seen for coronary revascularization and for lower-extremity amputation, new findings from the EUCLID ...

Please provide your email address to receive an email when new articles are posted on . Symvess is a sterile, cell-free tissue engineered vessel made of human extracellular matrix proteins. Among 54 ...

Revascularization is a procedure that can restore blood flow in blocked arteries or veins. For someone with peripheral artery disease (PAD), the operation can help ease symptoms and prevent serious ...

A 3-year, retrospective study by cardiologists from the Minneapolis Heart Institute Foundation and the University of Minnesota determined that 28.8% of patients with significant coronary artery ...

DURHAM, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at ...